MedPath
NMPA Approval

Salmeterol Xinafoate and Fluticasone Propionate Inhalation Aerosol

国药准字HJ20140403

April 18, 2024

H20140403

Drug Information

沙美特罗替卡松吸入气雾剂

舒利迭

吸入气雾剂

每瓶120揿,每揿含昔萘酸沙美特罗25μg(按C₂₅H₃₇NO₄计)和丙酸氟替卡松50μg,递送剂量为昔萘酸沙美特罗21μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松44μg。

化学药品

April 18, 2024

April 17, 2029

Company Information

Applicant Company

23 rue Francois Jacob 92500 Rueil-Malmaison-FRANCE

Manufacturing Company

Zone Industrielle n° 2, 23 rue Lavoisier, 27000 EVREUX-FRANCE

© Copyright 2025. All Rights Reserved by MedPath